Recent Finacing
Recent Raise
Interface Biologics is a University of Toronto spinoff and commercial-stage developer of biomedical-polymer technologies for medical devices, including heparin-free anti-thrombogenic coatings, anti-infective polymers, and programmable drug-delivery systems.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
